Oncogenic kinase signalling.

The hallmarks of cancer

Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219

Cell Signaling by Receptor Tyrosine Kinases

Lemmon, M. A., & Schlessinger, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.011 · Cited by 7,929

Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia

Druker, B. J., Talpaz, M., Resta, D. J., Peng, B., Buchdunger, E., Ford, J., Lydon, N., Kantarjian, H. M., Capdeville, R., Ohno-Jones, S., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441401 · Cited by 5,237

Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal Tumors

Hirota, S., Isozaki, K., Moriyama, Y., Hashimoto, K., Nishida, T., Ishiguro, S., Kawano, K., Hanada, M., Kurata, A., Takeda, M., et al. (1998) · Science · doi:10.1126/science.279.5350.577 · Cited by 4,487

Cellular survival: a play in three Akts

Datta, S. R., Brunet, A., & Greenberg, M. E. (1999) · Genes & Development · doi:10.1101/gad.13.22.2905 · Cited by 4,216

STATs and Gene Regulation

Darnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979

Cell Signaling by Receptor Tyrosine Kinases

Schlessinger, J. (2000) · Cell · doi:10.1016/s0092-8674(00)00114-8 · Cited by 3,774

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells

Druker, B. J., Tamura, S., Buchdunger, E., Ohno-Jones, S., Segal, G. M., Fanning, S., Zimmermann, J., & Lydon, N. (1996) · Nature Medicine · doi:10.1038/nm0596-561 · Cited by 3,652

Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome

Druker, B. J., Sawyers, C. L., Kantarjian, H., Resta, D. J., Reese, S. F., Ford, J. M., Capdeville, R., & Talpaz, M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441402 · Cited by 2,713

Signaling—2000 and Beyond

Hunter, T. (2000) · Cell · doi:10.1016/s0092-8674(00)81688-8 · Cited by 2,586

Imaging of EGFR and EGFR Tyrosine Kinase Overexpression in Tumors by Nuclear Medicine Modalities

Mishani, E., Abourbeh, G., Eiblmaier, M., & Anderson, C. J. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208786404326 · Cited by 76

Development of a series of novel 4-anlinoquinazoline derivatives possessing quinazoline skeleton: Design, synthesis, EGFR kinase inhibitory efficacy, and evaluation of anticancer activities in vitro

Chang, J. K., Ren, H., Zhao, M., Yan, C., Zhao, W., He, Y., Zhao, Y., Zhang, H., & Qi, C. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.07.005 · Cited by 76

The location of KIT and PDGFRA gene mutations in gastrointestinal stromal tumours is site and phenotype associated

Penzel, R., Aulmann, S., Moock, M., Schwarzbach, M., Rieker, R. J., & Mechtersheimer, G. (2005) · Journal of Clinical Pathology · doi:10.1136/jcp.2004.021766 · Cited by 75

Glucose addiction in cancer therapy: advances and drawbacks

Granja, S., Pinheiro, C. M., Reis, R. M., Martinho, O., & Baltazar, F. (2015) · Current Drug Metabolism · doi:10.2174/1389200216666150602145145 · Cited by 74

A recent update on small‐molecule kinase inhibitors for targeted cancer therapy and their therapeutic insights from mass spectrometry‐based proteomic analysis

Lee, P. Y., Yeoh, Y., & Low, T. Y. (2022) · FEBS Journal · doi:10.1111/febs.16442 · Cited by 79

Fusion tyrosine kinases: a result and cause of genomic instability

Penserga, E. T. P., & Skórski, T. (2006) · Oncogene · doi:10.1038/sj.onc.1209756 · Cited by 75

Surmounting the resistance against EGFR inhibitors through the development of thieno[2,3-d]pyrimidine-based dual EGFR/HER2 inhibitors

Milik, S. N., Abdel‐Aziz, A. K., Lasheen, D. S., Serya, R. A. T., Minucci, S., & Abouzid, K. A. M. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.06.011 · Cited by 75

The Kinase Activity of Fibroblast Growth Factor Receptor 3 with Activation Loop Mutations Affects Receptor Trafficking and Signaling

Lievens, P., Mutinelli, C., Baynes, D., & Liboi, E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405247200 · Cited by 75

Protein nanoarray on Prolinker™ surface constructed by atomic force microscopy dip‐pen nanolithography for analysis of protein interaction

Lee, M.-S., Kang, D., Yang, H., Park, K., Choe, S. Y., Kang, C., Chang, S., Han, M. H., & Kang, I. (2006) · PROTEOMICS · doi:10.1002/pmic.200500392 · Cited by 75

Per2 Inhibits K562 Leukemia Cell Growth In Vitro and In Vivo Through Cell Cycle Arrest and Apoptosis Induction

Sun, C., Huang, S.-F., Zeng, J., Liu, D.-B., Xiao, Q., Tian, W., Zhu, X., Huang, Z.-G., & Feng, W. (2009) · Pathology & Oncology Research · doi:10.1007/s12253-009-9227-0 · Cited by 77

Mitogenic Signal Transduction Pathways in Meningiomas: Novel Targets for Meningioma Chemotherapy?

Johnson, M. D., & Toms, S. A. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000189834.63951.81 · Cited by 74

Oncogenic gene fusions in epithelial carcinomas

Prensner, J. R., & Chinnaiyan, A. M. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.11.008 · Cited by 73

CanProVar: a human cancer proteome variation database

Li, J., Duncan, D. T., & Zhang, B. (2010) · Human Mutation · doi:10.1002/humu.21176 · Cited by 72

Exploring higher-order EGFR oligomerisation and phosphorylation—a combined experimental and theoretical approach

Kozer, N., Barua, D., Orchard, S. G., Nice, E. C., Burgess, A. W., Hlavacek, W. S., & Clayton, A. H. A. (2013) · Molecular BioSystems · doi:10.1039/c3mb70073a · Cited by 74

Correlation of F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value and EGFR mutations in advanced lung adenocarcinoma

Huang, C., Yen, R., Cheng, M., Hsu, Y.-C., Wei, P., Tsai, Y., Tsai, M., Shih, J., Yang, C.-H., & Yang, P. (2009) · Medical Oncology · doi:10.1007/s12032-008-9160-1 · Cited by 75

Trafficking of Lyn through the Golgi caveolin involves the charged residues on αE and αI helices in the kinase domain

Kasahara, K., Nakayama, Y., Ikeda, K., Fukushima, Y., Matsuda, D., Horimoto, S., & Yamaguchi, N. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200403011 · Cited by 75

Protein and Proteome Phosphorylation Stoichiometry Analysis by Element Mass Spectrometry

Krüger, R., Kübler, H.-D., Pallissé, R., Burkovski, A., & Lehmann, W. D. (2006) · Analytical Chemistry · doi:10.1021/ac051896z · Cited by 74

Mutations in the tyrosine kinase domain of FLT3 define a new molecular mechanism of acquired drug resistance to PTK inhibitors in FLT3-ITD–transformed hematopoietic cells

Bagrintseva, K., Schwab, R., Kohl, T. M., Schnittger, S., Eichenlaub, S., Ellwart, J. W., Hiddemann, W., & Spiekermann, K. (2003) · Blood · doi:10.1182/blood-2003-05-1653 · Cited by 77

Inhibition of Src Family Kinases and Non-Classical Protein Kinases C Induce a Reeler-Like Malformation of Cortical Plate Development

Jossin, Y., Ogawa, M., Métin, C., Tissir, F., & Goffinet, A. M. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-30-09953.2003 · Cited by 73

Protein tyrosine kinases: autoregulation and small-molecule inhibition

Hubbard, S. R. (2002) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(02)00383-4 · Cited by 77

Design, modification and 3D QSAR studies of novel naphthalin-containing pyrazoline derivatives with/without thiourea skeleton as anticancer agents

Wen, Y., Hu, Y., Yang, Y., Zhang, F., Zhang, Y., Wang, X.-L., Tang, J.-F., Zhong, W., & Zhu, H. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.01.013 · Cited by 73

Genetic deregulation of the PIK3CA oncogene in oral cancer

Murugan, A. K., Munirajan, A. K., & Tsuchida, N. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.04.005 · Cited by 73

Endogenous ouabain regulates cell viability

Dvela‐Levitt, M., Rosen, H., Ben-Ami, H. C., & Lichtstein, D. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00336.2011 · Cited by 73

The Shc adaptor protein is critical for VEGF induction by Met/HGF and ErbB2 receptors and for early onset of tumor angiogenesis

Saucier, C., Khoury, H., Lai, K. V., Peschard, P., Dankort, D. L., Naujokas, M. A., Holash, J. A., Yancopoulos, G. D., Muller, W. J., Pawson, T. J., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308065101 · Cited by 77

Obesity, hyperinsulinemia and breast cancer: novel targets and a novel role for metformin

Wysocki, P. J., & Wierusz‐Wysocka, B. (2010) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.10.22 · Cited by 73

Activation of transmembrane cell‐surface receptors via a common mechanism? The “rotation model”

MARUYAMA, I. N. (2015) · BioEssays · doi:10.1002/bies.201500041 · Cited by 72

PI3K/Akt signaling pathway triggers P2X7 receptor expression as a pro-survival factor of neuroblastoma cells under limiting growth conditions

Gómez‐Villafuertes, R., García-Huerta, P., Díaz‐Hernandéz, J. I., & Miras‐Portugal, M. T. (2015) · Scientific Reports · doi:10.1038/srep18417 · Cited by 72

Receptor Tyrosine Kinase Fusions as an Actionable Resistance Mechanism to EGFR TKIs in EGFR-Mutant Non-Small-Cell Lung Cancer

Zhu, V. W., Klempner, S. J., & Ou, S. I. (2019) · Trends in cancer · doi:10.1016/j.trecan.2019.09.008 · Cited by 73

Sole BCR-ABL inhibition is insufficient to eliminate all myeloproliferative disorder cell populations

Wong, S., McLaughlin, J., Cheng, D., Zhang, C., Shokat, K. M., & Witte, O. N. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407061101 · Cited by 72

Bivalent inhibitors of protein kinases

Gower, C. M., Chang, M. E. K., & Maly, D. J. (2014) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.875513 · Cited by 71

Titanium Dioxide Coated MALDI Plate for On Target Analysis of Phosphopeptides

Torta, F. T., Fusi, M., Casari, C. S., Bottani, C. E., & Bachi, A. (2009) · Journal of Proteome Research · doi:10.1021/pr8008836 · Cited by 72

CrkI and CrkII Function as Key Signaling Integrators for Migration and Invasion of Cancer Cells

Rodrigues, S., Fathers, K. E., Chan, G., Zuo, D., Halwani, F., Meterissian, S. H., & Park, M. (2005) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-04-0211 · Cited by 72

Novel thienopyrimidine derivatives as dual EGFR and VEGFR-2 inhibitors: design, synthesis, anticancer activity and effect on cell cycle profile

Mghwary, A. E.-S., Gedawy, E. M., Kamal, A. M., & Abuel‐Maaty, S. M. (2019) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2019.1593160 · Cited by 72

Receptor tyrosine kinases in normal and malignant haematopoiesis

Reilly, J. T. (2003) · Blood Reviews · doi:10.1016/s0268-960x(03)00024-9 · Cited by 72

Quantification of the anti-leukemia drug STI571 (Gleevec™) and its metabolite (CGP 74588) in monkey plasma using a semi-automated solid phase extraction procedure and liquid chromatography-tandem mass spectrometry

Bakhtiar, R., Khemani, L., Hayes, M., Bedman, T., & Tse, F. L. S. (2002) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(02)00080-8 · Cited by 72

Adaptive stress signaling in targeted cancer therapy resistance

Pazarentzos, E., & Bivona, T. G. (2015) · Oncogene · doi:10.1038/onc.2015.26 · Cited by 73

Caloric restriction: is mammalian life extension linked to p53?

Tucci, P. (2012) · Aging · doi:10.18632/aging.100481 · Cited by 70

Microglia and mast cells generate proinflammatory cytokines in the brain and worsen inflammatory state: Suppressor effect of IL-37

Conti, P., Lauritano, D., Caraffa, A., Gallenga, C. E., Kritas, S. K., Ronconi, G., & Martinotti, S. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173035 · Cited by 71

CircCDK14 Promotes Tumor Progression and Resists Ferroptosis in Glioma by Regulating PDGFRA

Chen, S., Zhang, Z., Zhang, B., Huang, Q., Liu, Y., Qiu, Y., Long, X., Wu, M., & Zhang, Z. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.66114 · Cited by 72

Involvement of Golgi-associated Lyn tyrosine kinase in the translocation of annexin II to the endoplasmic reticulum under oxidative stress

Matsuda, D., Nakayama, Y., Horimoto, S., Kuga, T., Ikeda, K., Kasahara, K., & Yamaguchi, N. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.02.003 · Cited by 71

Identification of tyrosine-phosphorylated proteins associated with metastasis and functional analysis of FER in human hepatocellular carcinoma cells

Li, H., Ren, Z., Kang, X., Zhang, L., Li, X., Wang, Y., Xue, T., Shen, Y.-F., & Liu, Y. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-366 · Cited by 71

Mutations in the tyrosine kinase domain of the EGFR gene associated with gefitinib response in non-small-cell lung cancer

Rosell, R., Ichinose, Y., Tarón, M., Sarries, C., Queralt, C., Méndez, P., Sánchez, J. M., Nishiyama, K., Morán, T., Cirauqui, B., et al. (2005) · Lung Cancer · doi:10.1016/j.lungcan.2005.05.017 · Cited by 71

Frontal affinity chromatography with MS detection (FAC-MS) in drug discovery

Slon‐Usakiewicz, J. J., Ng, W., Dai, J.-R., Pasternak, A., & Redden, P. R. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03360-4 · Cited by 71

RNA interference: Implications for cancer treatment

Masiero, M., Nardo, G., Indraccolo, S., & Favaro, E. (2007) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2006.12.004 · Cited by 71

Synergic antitumoral effect of an IGF-IR inhibitor and trastuzumab on HER2-overexpressing breast cancer cells

Esparı́s-Ogando, A., Ocaña, A., Barrueco, R. R., Ferreira, L., Borges, J., & Pandiella, A. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn406 · Cited by 71

Low duplicability and network fragility of cancer genes

Rambaldi, D., Giorgi, F. M., Capuani, F., Ciliberto, A., & Ciccarelli, F. D. (2008) · Trends in Genetics · doi:10.1016/j.tig.2008.06.003 · Cited by 66

Leukocyte elastase induces epithelial apoptosis: role of mitochondial permeability changes and Akt

Ginzberg, H. H., Shannon, P. T., Suzuki, T., Hong, O., Vachon, E., Moraes, T. J., Abreu, M. T. H., Cherepanov, V., Wang, X., Chow, C., et al. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00350.2003 · Cited by 71

Inhibition of zebrafish epidermal growth factor receptor activity results in cardiovascular defects

Goishi, K., Lee, P., Davidson, A. J., Nishi, E., Zon, L. I., & Klagsbrun, M. (2003) · Mechanisms of Development · doi:10.1016/s0925-4773(03)00068-6 · Cited by 70

Mass Spectrometry Based Immunopeptidomics Leads to Robust Predictions of Phosphorylated HLA Class I Ligands

Solleder, M., Guillaume, P., Racle, J., Michaux, J., Pak, H.-S., Müller, M., Coukos, G., Bassani-Sternberg, M., & Gfeller, D. (2020) · Molecular & Cellular Proteomics · doi:10.1074/mcp.tir119.001641 · Cited by 68

Distinct Types of Disorder in the Human Proteome: Functional Implications for Alternative Splicing

Çolak, R., Kim, T. P., Michaut, M., Sun, M., Irimia, M., Bellay, J., Myers, C. L., Blencowe, B. J., & Kim, P. M. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003030 · Cited by 69

High-Throughput Discovery of Mycobacterium tuberculosis Protein Tyrosine Phosphatase B (MptpB) Inhibitors Using Click Chemistry

Tan, L. P., Wu, H., Yang, P., Kalesh, K., Zhang, X., Hu, M., Srinivasan, R., & Yao, S. Q. (2009) · Organic Letters · doi:10.1021/ol9023419 · Cited by 70

PET imaging with small-molecule tyrosine kinase inhibitors: TKI-PET

Slobbe, P., Poot, A. J., Windhorst, A. D., & van Dongen, G. A. M. S. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.06.016 · Cited by 70

Lipid rafts, KCa/ClCa/Ca2+ channel complexes and EGFR signaling: Novel targets to reduce tumor development by lipids?

Guéguinou, M., Gambade, A., Félix, R., Chantôme, A., Fourbon, Y., Bougnoux, P., Weber, G., Potier‐Cartereau, M., & Vandier, C. (2014) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2014.10.036 · Cited by 68

Load-Induced Modulation of Signal Transduction Networks

Jiang, P., Ventura, A. C., Sontag, E. D., Merajver, S. D., Ninfa, A. J., & Vecchio, D. D. (2011) · Science Signaling · doi:10.1126/scisignal.2002152 · Cited by 72

A novel controlled release formulation of the Pin1 inhibitor ATRA to improve liver cancer therapy by simultaneously blocking multiple cancer pathways

Yang, D., Luo, W., Wang, J., Zheng, M., Liao, X., Zhang, N., Lu, W., Wang, L., Chen, A., Wu, W., et al. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.11.031 · Cited by 69

Nimotuzumab: beyond the EGFR signaling cascade inhibition

Mazorra, Z., Chao, L., Lavastida, A., Sanchez, B., Ramos, M., Iznaga, N., & Crombet, T. (2018) · Seminars in Oncology · doi:10.1053/j.seminoncol.2018.04.008 · Cited by 74

Role of tyrosine phosphorylation in modulating cancer cell metabolism

Taddei, M. L., Pardella, E., Pranzini, E., Raugei, G., & Paoli, P. D. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188442 · Cited by 70

Evidence for phosphatidylinositol 3-kinase—Akt—p70S6K pathway activation and transduction of mitogenic signals by platelet-derived growth factor in human meningioma cells

Johnson, M. D., Okediji, E., Woodard, A., Toms, S. A., & Allen, G. S. (2002) · Journal of neurosurgery · doi:10.3171/jns.2002.97.3.0668 · Cited by 69

Protein kinases and the proteasome join in the combinatorial control of transcription by nuclear retinoic acid receptors

Bour, G., Lalevée, S., & Rochette‐Egly, C. (2007) · Trends in Cell Biology · doi:10.1016/j.tcb.2007.04.003 · Cited by 76

The emerging pathogenic and therapeutic importance of the anaplastic lymphoma kinase gene

Kelleher, F. C., & McDermott, R. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.04.006 · Cited by 71

The NPM-ALK tyrosine kinase mimics TCR signalling pathways, inducing NFAT and AP-1 by RAS-dependent mechanisms

Turner, S. D., Yeung, D., Hadfield, K., Cook, S. J., & Alexander, D. R. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.09.007 · Cited by 69

Increased PTP1B expression and phosphatase activity in colorectal cancer results in a more invasive phenotype and worse patient outcome

Hoekstra, E., Das, A. M., Swets, M., Cao, W., van der Woude, C. J., Bruno, M. J., Peppelenbosch, M. P., Kuppen, P. J. K., ten Hagen, T. L. M., & Fuhler, G. M. (2016) · Oncotarget · doi:10.18632/oncotarget.7829 · Cited by 68

Optogenetic toolkit for precise control of calcium signaling

Ma, G., Wen, S., He, L., Huang, Y., Wang, Y., & Zhou, Y. (2017) · Cell Calcium · doi:10.1016/j.ceca.2017.01.004 · Cited by 69

MiR-337–3p suppresses proliferation of epithelial ovarian cancer by targeting PIK3CA and PIK3CB

Zhang, Z., Zhang, L., Wang, B., Wei, R., Wang, Y., Wan, J., Zhang, C., Zhao, L., Zhu, X., Zhang, Y., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.10.021 · Cited by 67

A Monoclonal Antibody to Visualize PtdIns(3,4,5)P 3 in Cells

Chen, R., Kang, V. H., Chen, J., Shope, J. C., Torabinejad, J., DeWald, D. B., & Prestwich, G. D. (2002) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540205000511 · Cited by 69

Mitochondrial oxidative stress plays a critical role in the cardiotoxicity of sunitinib

Bouitbir, J., Alshaikhali, A., Panajatovic, M. V., Abegg, V. F., Paech, F., & Krähenbühl, S. (2019) · Toxicology · doi:10.1016/j.tox.2019.152281 · Cited by 68

Role of Focal Adhesion Kinase in Small-Cell Lung Cancer and Its Potential as a Therapeutic Target

Nana, F. A., Vanderputten, M., & Ocak, S. (2019) · Cancers · doi:10.3390/cancers11111683 · Cited by 69

Spatiotemporally resolved subcellular phosphoproteomics

Liu, Y., Zeng, R., Wang, R., Weng, Y., Wang, R., Zou, P., & Chen, P. R. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2025299118 · Cited by 68

MEK1 signaling mediates transformation and metastasis of EpH4 mammary epithelial cells independent of an epithelial to mesenchymal transition.

Pinkas, J., & Leder, P. (2002) · PubMed · Cited by 68

Profiling, comparison and validation of gene expression in gastric carcinoma and normal stomach

Oien, K. A., Vass, J. K., Downie, I., Fullarton, G. M., & Keith, W. N. (2003) · Oncogene · doi:10.1038/sj.onc.1206615 · Cited by 68

Phosphorylation of the mutant K303R estrogen receptor α at serine 305 affects aromatase inhibitor sensitivity

Barone, I., Iacopetta, D., Covington, K. R., Cui, Y., Tsimelzon, A. I., Beyer, A. R., Andò, S., & Fuqua, S. A. W. (2010) · Oncogene · doi:10.1038/onc.2009.520 · Cited by 68

High glucose levels promote the proliferation of breast cancer cells through GTPases

Hou, Y., Zhou, M., Xie, J., Chao, P., Feng, Q., & Wu, J. (2017) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s135665 · Cited by 68

Caspase-Dependent Cleavage of c-Abl Contributes to Apoptosis

Barilà, D., Rufini, A., Condò, I., Ventura, N., Dorey, K., Superti‐Furga, G., & Testi, R. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.8.2790-2799.2003 · Cited by 68

Further evidence that the rs1858830 C variant in the promoter region of the MET gene is associated with autistic disorder

Jackson, P. B., Boccuto, L., Skinner, C., Collins, J. S., Neri, G., Gurrieri, F., & Schwartz, C. E. (2009) · Autism Research · doi:10.1002/aur.87 · Cited by 65

CIP2A is over‐expressed in acute myeloid leukaemia and associated with HL60 cells proliferation and differentiation

Wang, J., LI, W., Li, L., Yu, X., Jia, J., & Chen, C. (2011) · International Journal of Laboratory Hematology · doi:10.1111/j.1751-553x.2010.01288.x · Cited by 66

Allosteric Communication across the Native and Mutated KIT Receptor Tyrosine Kinase

Laine, É., Auclair, C., & Tchertanov, L. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002661 · Cited by 65

S6K1-mediated phosphorylation of PDK1 impairs AKT kinase activity and oncogenic functions

Jiang, Q., Zhang, X., Dai, X., Han, S., Wu, X., Wang, L., Wei, W., Zhang, N., Xie, W., & Guo, J. (2022) · Nature Communications · doi:10.1038/s41467-022-28910-8 · Cited by 68

Medicinal Chemistry of Quinazolines as Anticancer Agents Targeting Tyrosine Kinases

Zayed, M. F. (2023) · Scientia Pharmaceutica · doi:10.3390/scipharm91020018 · Cited by 67

Promise and Progress for Functional and Molecular Imaging of Response to Targeted Therapies

Stephen, R. M., & Gillies, R. J. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9250-3 · Cited by 67

A Boolean-based systems biology approach to predict novel genes associated with cancer: Application to colorectal cancer

Nagaraj, S. H., & Reverter, A. (2011) · BMC Systems Biology · doi:10.1186/1752-0509-5-35 · Cited by 66

Cancer-associated Mutations Activate the Nonreceptor Tyrosine Kinase Ack1

Prieto-Echagüe, V., Gucwa, A. L., Craddock, B. P., Brown, D. A., & Miller, W. T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.060459 · Cited by 67

Plasma and tissue insulin-like growth factor-I receptor (IGF-IR) as a prognostic marker for prostate cancer and anti-IGF-IR agents as novel therapeutic strategy for refractory cases: A review

Özkan, E. E. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.07.002 · Cited by 67

Prevalence, clinico-pathological value, and co-occurrence of PDGFRA abnormalities in diffuse gliomas

Alentorn, A., Marie, Y., Carpentier, C., Boisselier, B., Giry, M., Labussière, M., Mokhtari, K., Hoang‐Xuan, K., Sanson, M., Delattre, J., et al. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos217 · Cited by 67

Effects of Cancer-Associated EPHA3 Mutations on Lung Cancer

Zhuang, G., Song, W., Amato, K. R., Hwang, Y., Lee, K., Boothby, M. R., Ye, F., Guo, Y., Shyr, Y., Lin, L., et al. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs297 · Cited by 68

Prolyl Isomerase Pin1 Regulates Neuronal Differentiation via β-Catenin

Nakamura, K., Kosugi, I., Lee, D. Y., Hafner, A. V., Sinclair, D. A., Ryo, A., & Lu, K. P. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.05688-11 · Cited by 69

Receptor Tyrosine Kinase Ubiquitination and De-Ubiquitination in Signal Transduction and Receptor Trafficking

Critchley, W. R., Pellet‐Many, C., Ringham-Terry, B., Harrison, M. A., Zachary, I. C., & Ponnambalam, S. (2018) · Cells · doi:10.3390/cells7030022 · Cited by 71

Identification of lead molecules against potential drug target protein MAPK4 from L. donovani: An in-silico approach using docking, molecular dynamics and binding free energy calculation

Raj, S., Sasidharan, S., Dubey, V. K., & Saudagar, P. (2019) · PLoS ONE · doi:10.1371/journal.pone.0221331 · Cited by 66

Proto‐oncogene TCL1: more than just a coactivator for Akt

Noguchi, M., Ropars, V., Roumestand, C., & Suizu, F. (2007) · The FASEB Journal · doi:10.1096/fj.06-7684com · Cited by 67

Novel Agents for the Prevention of Breast Cancer: Targeting Transcription Factors and Signal Transduction Pathways

Shen, Q., & Brown, P. H. (2003) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1025783221557 · Cited by 65

2-(2-(2,4-dioxopentan-3-ylidene)hydrazineyl)benzonitrile as novel inhibitor of receptor tyrosine kinase and PI3K/AKT/mTOR signaling pathway in glioblastoma

Viswanathan, A., Kute, D., Musa, A., Saravanan, K. M., Sipilä, V., Emmert‐Streib, F., Zubkov, F. I., Gurbanov, A. V., Yli-Harja, O. P., & Kandhavelu, M. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.01.021 · Cited by 68

Ligand bias in receptor tyrosine kinase signaling

Karl, K., Paul, M. D., Pasquale, E. B., & Hristova, K. A. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.015190 · Cited by 68

High-Density, Targeted Monitoring of Tyrosine Phosphorylation Reveals Activated Signaling Networks in Human Tumors

Stopfer, L. E., Flower, C. T., Gajadhar, A. S., Patel, B., Gallien, S., López‐Ferrer, D., & White, F. M. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-3804 · Cited by 67

Modulation of mitochondrial apoptosis by PI3K inhibitors

Fulda, S. (2012) · Mitochondrion · doi:10.1016/j.mito.2012.05.001 · Cited by 67

ABT-869, a promising multi-targeted tyrosine kinase inhibitor: from bench to bedside

Zhou, J., Goh, B.-C., Albert, D. H., & Chen, C.-S. (2009) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-2-33 · Cited by 65

Malignant glioma drug discovery – targeting protein kinases

Sathornsumetee, S., Vredenburgh, K. A., Lattimore, K. P., & Rich, J. N. (2007) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2.1.1 · Cited by 65

Pancreatic endocrine tumours: mutational and immunohistochemical survey of protein kinases reveals alterations in targetable kinases in cancer cell lines and rare primaries

Corbo, V., Beghelli, S., Bersani, S., Antonello, D., Talamini, G., Brunelli, M., Capelli, P., Falconi, M., & Scarpa, A. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr048 · Cited by 67

CSF-1 signaling in macrophages: pleiotrophy through phosphotyrosine-based signaling pathways

Mouchemore, K. A., & Pixley, F. J. (2012) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2012.666845 · Cited by 70

Intersectin Regulates Epidermal Growth Factor Receptor Endocytosis, Ubiquitylation, and Signaling

Martin, N. P., Mohney, R. P., Dunn, S., Das, M., Scappini, E., & O’Bryan, J. P. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.028274 · Cited by 66

Identification of Fer Tyrosine Kinase Localized on Microtubules as a Platelet Endothelial Cell Adhesion Molecule-1 Phosphorylating Kinase in Vascular Endothelial Cells

Kogata, N., Masuda, M., Kamioka, Y., Yamagishi, A., Endo, A., Okada, M., & Mochizuki, N. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-02-0080 · Cited by 66

Cancer metastasis therapeutic targets and drug discovery: emerging small-molecule protein kinase inhibitors

Sawyer, T. K. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.1.1 · Cited by 65

The Akt kinase: Molecular determinants of oncogenicity

Aoki, M., Batista, O., Bellacosa, A., Tsichlis, P. N., & Vogt, P. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14950 · Cited by 294

PI3K/PTEN/AKT pathway. A critical mediator of oncogenic signaling.

Paez, J., & Sellers, W. R. (2003) · PubMed · Cited by 172

Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic

Kang, S., Bader, A. G., & Vogt, P. K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408864102 · Cited by 827

Phosphatidylinositol-3 kinase dependent pathways: the role in control of cell growth, survival, and malignant transformation.

Ma, K. (2000) · PubMed · Cited by 277

Tyrosine Kinase Signaling Pathways in Normal and Cancer Cells

Marcinkowska, E., & Gocek, E. (2016) · Resistance to targeted anti-cancer therapeutics · doi:10.1007/978-3-319-46091-8_1 · Cited by 1